# Menstrual Migraine Treatment With TREXIMET (Formerly Known as TREXIMA)

> **NCT00329355** · PHASE3 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 351 (actual)

## Conditions studied

- Migraine
- Migraine Disorders

## Interventions

- **DRUG:** sumatriptan succinate/naproxen sodium

## Key facts

- **NCT ID:** NCT00329355
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-05
- **Primary completion:** 2006-11
- **Final completion:** 2006-11
- **Target enrollment:** 351 (ACTUAL)
- **Last updated:** 2017-01-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00329355

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00329355, "Menstrual Migraine Treatment With TREXIMET (Formerly Known as TREXIMA)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00329355. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*